Rising Demand for Convenient Obesity and Diabetes Therapies The rising number of cases of obesity and type 2 diabetes will contribute significantly to the market's expansion within the forecast period
And remember: as a SemaPen subscriber, you have direct access to expert support from our team
PRESS RELEASE GLP-1 Weight Loss Users Are Seeking Smaller Pack Sizes and Foods with Functional Benefits, according to new study from AMC Global and OpinionRoute AMC Global, an international custom market research firm specializing in launch strategies and brand tracking, and OpinionRoute, a leader in insights process management, have released a new study on GLP-1 medication users and food choices
Semaglutide is an injectable medication that, when used in combination with diet and exercise, helps with blood sugar control in type 2 diabetics and assists in weight loss
They source pharmaceutical-grade tirzepatide powder, combine it with B12 and other excipients, and perform sterile compounding in controlled environments